STAT1-independent inhibition of cyclooxygenase-2 expression by IFNγ;: a common pathway of IFNγ-mediated gene repression but not gene activation

被引:19
作者
Klampfer, L.
Huang, J.
Kaler, P.
Sasazuki, T.
Shirasawa, S.
Augenlicht, L.
机构
[1] Montefiore Med Ctr, Albert Einstein Canc Ctr, Dept Oncol, Bronx, NY 10467 USA
[2] Int Med Ctr Japan, Inst Res, Shinjuku Ku, Tokyo, Japan
关键词
STAT1; COX-2; JAK; IFN; colon ucancer;
D O I
10.1038/sj.onc.1210015
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cyclooxygenase-2 (COX-2), the rate-limiting enzyme in the synthesis of prostaglandins, promotes the development of colorectal cancer, and is a key molecular target of nonsteroidal anti-inflammatory drugs, compounds that reduce the relative risk of developing colon cancer. In this study, we showed that interferon gamma (IFN gamma) inhibits the expression of COX-2 protein in intestinal epithelial cells (IECs) through a pathway that requires Janus-activated kinase (JAK) activity. In contrast, we demonstrated that transcriptional inhibition of COX-2 by IFN beta or IFN gamma occurs in cells with silenced signal transducer and activator of transcription 1 (STAT1) expression and that IFNs retained the ability to inhibit COX-2 transcription in cells with activated RasV12, in which IFN gamma failed to induce STAT1. Thus, unlike the activity of JAK, STAT1 is not required for the inhibition of COX-2 expression by IFN gamma. In contrast to COX-2, the activation of genes in response to IFN gamma, such as interferon regulatory factor-1, was severely impaired by both STAT1 silencing and by constitutive Ras signaling. To determine whether there is a general differential requirement for STAT1 in gene activation and gene repression in response to IFN gamma in intestinal cells, we performed genome-wide analysis of IFN gamma target genes in an IEC line in which STAT1 expression was silenced by small interfering RNA. The results confirmed that the activation of the majority of genes by IFN gamma required STAT1. In contrast, the repression of several genes, as we showed for COX-2 specifically, was largely unaffected in cells with silenced STAT1. Our results therefore demonstrate that in general gene activation by IFNc is more sensitive to STAT1 deficiency than gene repression, and suggest that IFNc activates and represses gene expression via distinct pathways that can be distinguished, at least in part, by their requirement for STAT1.
引用
收藏
页码:2071 / 2081
页数:11
相关论文
共 51 条
[1]   Unresponsiveness to interferon associated with STAT1 protein deficiency in a gastric adenocarcinoma cell line [J].
Abril, E ;
Real, LM ;
Serrano, A ;
Jimenez, P ;
García, A ;
Canton, J ;
Trigo, I ;
Garrido, F ;
Ruiz-Cabello, F .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 1998, 47 (02) :113-120
[2]  
Araki Y, 2003, CANCER RES, V63, P728
[3]   Negative regulation of the alpha interferon-induced antiviral response by the Ras/Raf/MEK pathway [J].
Battcock, SA ;
Collier, TW ;
Zu, D ;
Hirasawa, K .
JOURNAL OF VIROLOGY, 2006, 80 (09) :4422-4430
[4]   Cancer surveillance in ulcerative colitis: critical analysis of long-term prospective programme [J].
Biasco, G ;
Rossini, FP ;
Hakim, R ;
Brandi, G ;
Di Battista, M ;
Di Febo, G ;
Calabrese, C ;
Santucci, R ;
Miglioli, M .
DIGESTIVE AND LIVER DISEASE, 2002, 34 (05) :339-342
[5]   SOX9 is an intestine crypt transcription factor, is regulated by the Wnt pathway, and represses the CDX2 and MUC2 genes [J].
Blache, P ;
van de Wetering, M ;
Duluc, I ;
Domon, C ;
Berta, P ;
Freund, JN ;
Clevers, H ;
Jay, P .
JOURNAL OF CELL BIOLOGY, 2004, 166 (01) :37-47
[6]   Interferon regulatory factor (IRF)-1 and IRF-2 regulate interferon γ-dependent cyclooxygenase 2 expression [J].
Blanco, JCG ;
Contursi, C ;
Salkowski, CA ;
DeWitt, DL ;
Ozato, K ;
Vogel, SN .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (12) :2131-2144
[7]   COX-2: A molecular target for colorectal cancer prevention [J].
Brown, JR ;
DuBois, RN .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (12) :2840-2855
[8]   Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms [J].
Bruewer, M ;
Luegering, A ;
Kucharzik, T ;
Parkos, CA ;
Madara, JL ;
Hopkins, AM ;
Nusrat, A .
JOURNAL OF IMMUNOLOGY, 2003, 171 (11) :6164-6172
[9]  
Clifford JL, 2002, CLIN CANCER RES, V8, P2067
[10]   RNA-dependent protein kinase PKR is required for activation of NF-κB by IFN-γ in a STAT1-independent pathway [J].
Deb, A ;
Haque, SJ ;
Mogensen, T ;
Silverman, RH ;
Williams, BRG .
JOURNAL OF IMMUNOLOGY, 2001, 166 (10) :6170-6180